We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Hikma Pharmaceuticals Plc | LSE:HIK | London | Ordinary Share | GB00B0LCW083 | ORD SHS 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
41.00 | 2.26% | 1,854.00 | 1,839.00 | 1,841.00 | 1,882.00 | 1,750.00 | 1,750.00 | 666,237 | 16:35:14 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 2.88B | 192M | 0.8685 | 21.17 | 4.07B |
TIDMHIK
RNS Number : 8710S
Hikma Pharmaceuticals Plc
14 March 2019
Notification and public disclosure of transactions by persons discharging managerial responsibilities
1 Details of the person discharging managerial responsibilities / person closely associated a) Name Dr. Pamela Kirby 2 Reason for the notification a) Position/status Non-executive Director b) Initial notification Initial notification /Amendment 3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor a) Name Hikma Pharmaceuticals PLC b) LEI 549300BNS685UXH4JI75 4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted a) Description of Description: Ordinary shares of 10 pence each the financial (Shares) instrument, type ID Code: GB00B0LCW083 of instrument and identification code b) Nature of the Market purchase of 1,500 Ordinary Shares by transaction Dr. Pamela Kirby. c) Price(s) and Price(s): GBP15.86 volume(s) Volume(s): 1,500 d) Aggregated information * Volume 1,500 GBP23,790.00 * Price e) Date of the transaction 14 March 2019 f) Place of the London Stock Exchange (XLON) transaction
Peter Speirs
Company Secretary, responsible for releasing this announcement
+44 (0) 20 7399 2760
14 March 2019
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
DSHGCGDXBBBBGCS
(END) Dow Jones Newswires
March 14, 2019 05:14 ET (09:14 GMT)
1 Year Hikma Pharmaceuticals Chart |
1 Month Hikma Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions